Mr Omar Chebbo
Montpellier (France)
Real-life adverse events with SGLT-2 inhibitors: different safety profiles according to their indications?
Event: Heart Failure 2024
Topic: Antidiabetic Pharmacotherapy
Session: Pharmacology and pharmacotherapy
